Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 2
2014 3
2015 1
2016 2
2017 2
2018 3
2020 3
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
Techniques and assays for the study of angiogenesis.
Irvin MW, Zijlstra A, Wikswo JP, Pozzi A. Irvin MW, et al. Exp Biol Med (Maywood). 2014 Nov;239(11):1476-88. doi: 10.1177/1535370214529386. Epub 2014 May 28. Exp Biol Med (Maywood). 2014. PMID: 24872440 Free PMC article. Review.
Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?
Biffi R, Toro A, Pozzi S, Di Carlo I. Biffi R, et al. Support Care Cancer. 2014 Jun;22(6):1705-14. doi: 10.1007/s00520-014-2208-1. Support Care Cancer. 2014. PMID: 24659216 Review.
The first placement of a totally implantable central venous access device (TIVAD) was performed in 1982 at the MD Anderson Cancer Center in Houston by John Niederhuber, using the cephalic vein-exposed by surgical cut-down-as route of access to central veins. ...
The first placement of a totally implantable central venous access device (TIVAD) was performed in 1982 at the MD Anderson Cancer Center in …
Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy.
Aameish M, Jovanovic M, John MA, Baumstein D. Aameish M, et al. Cureus. 2021 Nov 10;13(11):e19446. doi: 10.7759/cureus.19446. eCollection 2021 Nov. Cureus. 2021. PMID: 34912597 Free PMC article.
In this case report, we present a 44-year-old male with proteinuria and biopsy-proven IgAN who remained in remission after six months of steroids using the Pozzi protocol. He developed proteinuria five years after remission. ...
In this case report, we present a 44-year-old male with proteinuria and biopsy-proven IgAN who remained in remission after six months of ste …
A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
Pozzi L, Schmidli H, Ohlssen DI. Pozzi L, et al. Pharm Stat. 2016 Jul;15(4):341-8. doi: 10.1002/pst.1749. Epub 2016 Apr 7. Pharm Stat. 2016. PMID: 27061897
While the primary aim for developing this model was to support decision-making in drug development, the proposed model may also be considered for future validation. Copyright 2016 John Wiley & Sons, Ltd....
While the primary aim for developing this model was to support decision-making in drug development, the proposed model may also be considere …
Measurement of the 2νββ Decay Rate and Spectral Shape of ^{100}Mo from the CUPID-Mo Experiment.
Augier C, Barabash AS, Bellini F, Benato G, Beretta M, Bergé L, Billard J, Borovlev YA, Cardani L, Casali N, Cazes A, Celi E, Chapellier M, Chiesa D, Dafinei I, Danevich FA, De Jesus M, Dixon T, Dumoulin L, Eitel K, Ferri F, Fujikawa BK, Gascon J, Gironi L, Giuliani A, Grigorieva VD, Gros M, Helis DL, Huang HZ, Huang R, Imbert L, Johnston J, Juillard A, Khalife H, Kleifges M, Kobychev VV, Kolomensky YG, Konovalov SI, Kotila J, Loaiza P, Ma L, Makarov EP, de Marcillac P, Mariam R, Marini L, Marnieros S, Navick XF, Nones C, Norman EB, Olivieri E, Ouellet JL, Pagnanini L, Pattavina L, Paul B, Pavan M, Peng H, Pessina G, Pirro S, Poda DV, Polischuk OG, Pozzi S, Previtali E, Redon T, Rojas A, Rozov S, Sanglard V, Scarpaci JA, Schmidt B, Shen Y, Shlegel VN, Šimkovic F, Singh V, Tomei C, Tretyak VI, Umatov VI, Vagneron L, Velázquez M, Ware B, Welliver B, Winslow L, Xue M, Yakushev E, Zarytskyy M, Zolotarova AS; CUPID-Mo Collaboration. Augier C, et al. Phys Rev Lett. 2023 Oct 20;131(16):162501. doi: 10.1103/PhysRevLett.131.162501. Phys Rev Lett. 2023. PMID: 37925694
The MEST score provides earlier risk prediction in lgA nephropathy.
Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC; Oxford Derivation, North American Validation and VALIGA Consortia; Oxford Derivation North American Validation and VALIGA Consortia. Barbour SJ, et al. Kidney Int. 2016 Jan;89(1):167-75. doi: 10.1038/ki.2015.322. Kidney Int. 2016. PMID: 26759049 Free article.
21 results